[go: up one dir, main page]

IL186916A0 - Use of insp052 polypeptide for the preparation of a medicament for treating diseases - Google Patents

Use of insp052 polypeptide for the preparation of a medicament for treating diseases

Info

Publication number
IL186916A0
IL186916A0 IL186916A IL18691607A IL186916A0 IL 186916 A0 IL186916 A0 IL 186916A0 IL 186916 A IL186916 A IL 186916A IL 18691607 A IL18691607 A IL 18691607A IL 186916 A0 IL186916 A0 IL 186916A0
Authority
IL
Israel
Prior art keywords
medicament
preparation
treating diseases
insp052 polypeptide
insp052
Prior art date
Application number
IL186916A
Original Assignee
Bruno Antonsson
Amanda Proudfoot
Laboratoirs Serono Sa
Kontula Linda
Vilbois Francis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2006/062063 external-priority patent/WO2006120160A1/en
Application filed by Bruno Antonsson, Amanda Proudfoot, Laboratoirs Serono Sa, Kontula Linda, Vilbois Francis filed Critical Bruno Antonsson
Publication of IL186916A0 publication Critical patent/IL186916A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL186916A 2005-05-06 2007-10-25 Use of insp052 polypeptide for the preparation of a medicament for treating diseases IL186916A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05103791 2005-05-06
US68165105P 2005-05-17 2005-05-17
PCT/EP2006/062063 WO2006120160A1 (en) 2005-05-06 2006-05-04 Use of an immunoglobulin domain-containing cell surface recognition molecule for treating diseases

Publications (1)

Publication Number Publication Date
IL186916A0 true IL186916A0 (en) 2008-02-09

Family

ID=36694338

Family Applications (1)

Application Number Title Priority Date Filing Date
IL186916A IL186916A0 (en) 2005-05-06 2007-10-25 Use of insp052 polypeptide for the preparation of a medicament for treating diseases

Country Status (2)

Country Link
IL (1) IL186916A0 (en)
NO (1) NO20076269L (en)

Also Published As

Publication number Publication date
NO20076269L (en) 2007-12-05

Similar Documents

Publication Publication Date Title
ZA200703601B (en) Medicaments for the treatment or prevention of fibriotic diseases
IL186662A (en) Use of bis(thiohydrazide amide) for the preparation of a medicament for treating a human with cancer
IL177015A0 (en) Improved modalities for the treatment of degenerative diseases of the retina
IL178302A (en) Use of natalizumab for the preparation of a medicament for reducing the need for steroid treatment
IL193747A0 (en) New therapeutic combinations for the treatment of depression
IL176629A0 (en) Sulfonamide derivatives for the treatment of diseases
PL2056842T3 (en) Modified-galactosyl ceramide for the treatment of cancerous diseases
AP2006003669A0 (en) Sulfonamide derivatives for the treatment of diseases
TWI372056B (en) Novel medicament combinations for the treatment of respiratory diseases
IL192415A0 (en) Pharmaceutical composition for the treatment of nail diseases
IL196667A (en) Use of peptides for the manufacture of a medicament for treating inflammation
GB0410399D0 (en) The treatment of respiratory disease
GB0410398D0 (en) The treatment of respiratory disease
IL185444A0 (en) Novel drugs for treating respiratory diseases
IL240394B (en) Use of alemtuzumab for the preparation of a medicament for use as a second line therapy for the treatment of multiple sclerosis (ms)
GB0523961D0 (en) The treatment of ophthalmic diseases
GB0400802D0 (en) Compounds for the treatment of disease
GB2423072B (en) Regulating the administration of a clinical procedure
HU0500145D0 (en) Composition for the treatment of oral diseases
IL186916A0 (en) Use of insp052 polypeptide for the preparation of a medicament for treating diseases
GB0523964D0 (en) The treatment of ophthalmic diseases
EP1864671A4 (en) The use of hydrochloric acid for the manufacture of a medicament for the treatment of hypertension
ZA200606780B (en) Compounds for the treatment of diseases
GB0420867D0 (en) Compounds for the treatment of diseases
GB0425073D0 (en) Compounds for the treatment of diseases